DSM has entered into a multi-million dollar contract with Shire US Manufacturing, Inc. under which DSM will manufacture and supply specialty pharmaceutical products for Shire. During a period of three years, beginning April 2009, Shire will transition several products, including Carbatrol (carbamezepine), Intuniv (guanfacine extended release), Lialda (mesalamine), Pentasa (mesalamine) and Vyvanse (lisdexamfetamine dimesylate) from its Owings Mills, MD facility to DSM’s facility in Green...